nodes	percent_of_prediction	percent_of_DWPC	metapath
Conjugated Estrogens—ESR1—ovarian cancer	0.214	0.702	CbGaD
Conjugated Estrogens—ABCB1—ovarian cancer	0.091	0.298	CbGaD
Conjugated Estrogens—SLCO1A2—Chlorambucil—ovarian cancer	0.0656	0.15	CbGbCtD
Conjugated Estrogens—SLCO1B3—Paclitaxel—ovarian cancer	0.0364	0.0835	CbGbCtD
Conjugated Estrogens—ABCG2—Topotecan—ovarian cancer	0.0341	0.078	CbGbCtD
Conjugated Estrogens—SLCO1B3—Docetaxel—ovarian cancer	0.0263	0.0604	CbGbCtD
Conjugated Estrogens—ABCC1—Epirubicin—ovarian cancer	0.0256	0.0585	CbGbCtD
Conjugated Estrogens—ABCC1—Paclitaxel—ovarian cancer	0.0252	0.0577	CbGbCtD
Conjugated Estrogens—ABCC3—Doxorubicin—ovarian cancer	0.0221	0.0507	CbGbCtD
Conjugated Estrogens—ABCC2—Paclitaxel—ovarian cancer	0.0186	0.0427	CbGbCtD
Conjugated Estrogens—ABCC1—Docetaxel—ovarian cancer	0.0182	0.0417	CbGbCtD
Conjugated Estrogens—ABCC2—Carboplatin—ovarian cancer	0.0176	0.0402	CbGbCtD
Conjugated Estrogens—ABCG2—Paclitaxel—ovarian cancer	0.0169	0.0386	CbGbCtD
Conjugated Estrogens—ABCG2—Carboplatin—ovarian cancer	0.0159	0.0364	CbGbCtD
Conjugated Estrogens—ABCC1—Doxorubicin—ovarian cancer	0.0136	0.0311	CbGbCtD
Conjugated Estrogens—ABCC2—Docetaxel—ovarian cancer	0.0135	0.0309	CbGbCtD
Conjugated Estrogens—ABCB1—Topotecan—ovarian cancer	0.0123	0.0281	CbGbCtD
Conjugated Estrogens—ABCG2—Docetaxel—ovarian cancer	0.0122	0.0279	CbGbCtD
Conjugated Estrogens—ABCC2—Doxorubicin—ovarian cancer	0.0101	0.023	CbGbCtD
Conjugated Estrogens—ABCG2—Doxorubicin—ovarian cancer	0.00909	0.0208	CbGbCtD
Conjugated Estrogens—ABCB1—Vinorelbine—ovarian cancer	0.00865	0.0198	CbGbCtD
Conjugated Estrogens—CYP3A4—Topotecan—ovarian cancer	0.00736	0.0169	CbGbCtD
Conjugated Estrogens—ABCB1—Paclitaxel—ovarian cancer	0.00608	0.0139	CbGbCtD
Conjugated Estrogens—ESR2—ovarian follicle—ovarian cancer	0.0053	0.0777	CbGeAlD
Conjugated Estrogens—CYP3A4—Vinorelbine—ovarian cancer	0.00518	0.0119	CbGbCtD
Conjugated Estrogens—ABCB1—Docetaxel—ovarian cancer	0.0044	0.0101	CbGbCtD
Conjugated Estrogens—CYP3A4—Paclitaxel—ovarian cancer	0.00364	0.00835	CbGbCtD
Conjugated Estrogens—ESR1—ovarian follicle—ovarian cancer	0.00363	0.0532	CbGeAlD
Conjugated Estrogens—ABCB1—Doxorubicin—ovarian cancer	0.00328	0.00751	CbGbCtD
Conjugated Estrogens—CYP3A4—Docetaxel—ovarian cancer	0.00263	0.00603	CbGbCtD
Conjugated Estrogens—ESR2—oviduct—ovarian cancer	0.00233	0.0341	CbGeAlD
Conjugated Estrogens—ABCC11—embryo—ovarian cancer	0.00206	0.0302	CbGeAlD
Conjugated Estrogens—CYP3A4—Doxorubicin—ovarian cancer	0.00196	0.0045	CbGbCtD
Conjugated Estrogens—SLC51B—endometrium—ovarian cancer	0.00169	0.0248	CbGeAlD
Conjugated Estrogens—ESR1—oviduct—ovarian cancer	0.00159	0.0234	CbGeAlD
Conjugated Estrogens—ABCC11—gonad—ovarian cancer	0.0014	0.0205	CbGeAlD
Conjugated Estrogens—ABCC11—female reproductive system—ovarian cancer	0.00125	0.0183	CbGeAlD
Conjugated Estrogens—ABCC11—female gonad—ovarian cancer	0.00113	0.0166	CbGeAlD
Conjugated Estrogens—SLC51B—testis—ovarian cancer	0.00113	0.0166	CbGeAlD
Conjugated Estrogens—SLC51A—gonad—ovarian cancer	0.00112	0.0165	CbGeAlD
Conjugated Estrogens—ABCC11—testis—ovarian cancer	0.00101	0.0148	CbGeAlD
Conjugated Estrogens—SLC51A—female reproductive system—ovarian cancer	0.001	0.0147	CbGeAlD
Conjugated Estrogens—SLCO3A1—myometrium—ovarian cancer	0.000922	0.0135	CbGeAlD
Conjugated Estrogens—SLC51A—vagina—ovarian cancer	0.000907	0.0133	CbGeAlD
Conjugated Estrogens—SLCO4A1—myometrium—ovarian cancer	0.00084	0.0123	CbGeAlD
Conjugated Estrogens—SLC51A—testis—ovarian cancer	0.000809	0.0119	CbGeAlD
Conjugated Estrogens—SLC10A1—gonad—ovarian cancer	0.000728	0.0107	CbGeAlD
Conjugated Estrogens—SLCO3A1—uterine cervix—ovarian cancer	0.000717	0.0105	CbGeAlD
Conjugated Estrogens—COMT—myometrium—ovarian cancer	0.00071	0.0104	CbGeAlD
Conjugated Estrogens—SLCO1B3—vagina—ovarian cancer	0.000674	0.00988	CbGeAlD
Conjugated Estrogens—SLC10A1—female reproductive system—ovarian cancer	0.00065	0.00953	CbGeAlD
Conjugated Estrogens—Quinestrol—ESR1—ovarian cancer	0.000635	0.161	CrCbGaD
Conjugated Estrogens—SLCO4A1—decidua—ovarian cancer	0.000623	0.00913	CbGeAlD
Conjugated Estrogens—SLCO3A1—gonad—ovarian cancer	0.000602	0.00883	CbGeAlD
Conjugated Estrogens—SLC22A11—female reproductive system—ovarian cancer	0.000594	0.0087	CbGeAlD
Conjugated Estrogens—SLCO4A1—endometrium—ovarian cancer	0.000591	0.00867	CbGeAlD
Conjugated Estrogens—SLC51A—lymph node—ovarian cancer	0.000587	0.0086	CbGeAlD
Conjugated Estrogens—ESR2—epithelium—ovarian cancer	0.000585	0.00857	CbGeAlD
Conjugated Estrogens—ESR2—uterine cervix—ovarian cancer	0.00058	0.0085	CbGeAlD
Conjugated Estrogens—COMT—uterine cervix—ovarian cancer	0.000553	0.0081	CbGeAlD
Conjugated Estrogens—SLCO3A1—female reproductive system—ovarian cancer	0.000538	0.00788	CbGeAlD
Conjugated Estrogens—COMT—decidua—ovarian cancer	0.000526	0.00772	CbGeAlD
Conjugated Estrogens—SLC10A1—testis—ovarian cancer	0.000525	0.00769	CbGeAlD
Conjugated Estrogens—ESR2—endometrium—ovarian cancer	0.000524	0.00769	CbGeAlD
Conjugated Estrogens—ABCC3—decidua—ovarian cancer	0.00052	0.00762	CbGeAlD
Conjugated Estrogens—ESR1—myometrium—ovarian cancer	0.00051	0.00748	CbGeAlD
Conjugated Estrogens—COMT—endometrium—ovarian cancer	0.0005	0.00733	CbGeAlD
Conjugated Estrogens—ABCC1—myometrium—ovarian cancer	0.000494	0.00724	CbGeAlD
Conjugated Estrogens—SLCO1C1—testis—ovarian cancer	0.000493	0.00723	CbGeAlD
Conjugated Estrogens—ESR1—embryo—ovarian cancer	0.000491	0.0072	CbGeAlD
Conjugated Estrogens—SLCO4A1—female reproductive system—ovarian cancer	0.00049	0.00718	CbGeAlD
Conjugated Estrogens—SLCO3A1—female gonad—ovarian cancer	0.000489	0.00717	CbGeAlD
Conjugated Estrogens—ESR2—gonad—ovarian cancer	0.000486	0.00713	CbGeAlD
Conjugated Estrogens—SLCO3A1—vagina—ovarian cancer	0.000486	0.00713	CbGeAlD
Conjugated Estrogens—SLCO2B1—decidua—ovarian cancer	0.000485	0.00711	CbGeAlD
Conjugated Estrogens—ESR2—uterus—ovarian cancer	0.000483	0.00708	CbGeAlD
Conjugated Estrogens—Mestranol—ESR1—ovarian cancer	0.000481	0.122	CrCbGaD
Conjugated Estrogens—COMT—gonad—ovarian cancer	0.000464	0.0068	CbGeAlD
Conjugated Estrogens—COMT—uterus—ovarian cancer	0.000461	0.00675	CbGeAlD
Conjugated Estrogens—SLCO4A1—vagina—ovarian cancer	0.000443	0.0065	CbGeAlD
Conjugated Estrogens—ESR2—female reproductive system—ovarian cancer	0.000434	0.00637	CbGeAlD
Conjugated Estrogens—SLCO3A1—testis—ovarian cancer	0.000434	0.00636	CbGeAlD
Conjugated Estrogens—SLCO1B1—female reproductive system—ovarian cancer	0.000431	0.00632	CbGeAlD
Conjugated Estrogens—SLCO2B1—uterus—ovarian cancer	0.000424	0.00622	CbGeAlD
Conjugated Estrogens—Estriol—ESR1—ovarian cancer	0.00042	0.107	CrCbGaD
Conjugated Estrogens—COMT—female reproductive system—ovarian cancer	0.000414	0.00607	CbGeAlD
Conjugated Estrogens—ABCC3—female reproductive system—ovarian cancer	0.000409	0.006	CbGeAlD
Conjugated Estrogens—ABCG2—myometrium—ovarian cancer	0.000409	0.00599	CbGeAlD
Conjugated Estrogens—ESR1—epithelium—ovarian cancer	0.0004	0.00587	CbGeAlD
Conjugated Estrogens—ESR1—uterine cervix—ovarian cancer	0.000397	0.00582	CbGeAlD
Conjugated Estrogens—SLCO4A1—testis—ovarian cancer	0.000395	0.0058	CbGeAlD
Conjugated Estrogens—ESR2—female gonad—ovarian cancer	0.000395	0.0058	CbGeAlD
Conjugated Estrogens—ESR2—vagina—ovarian cancer	0.000393	0.00576	CbGeAlD
Conjugated Estrogens—COMT—bone marrow—ovarian cancer	0.000391	0.00573	CbGeAlD
Conjugated Estrogens—Estramustine—ESR1—ovarian cancer	0.00039	0.0991	CrCbGaD
Conjugated Estrogens—ABCC1—uterine cervix—ovarian cancer	0.000384	0.00563	CbGeAlD
Conjugated Estrogens—SLCO2B1—female reproductive system—ovarian cancer	0.000381	0.00559	CbGeAlD
Conjugated Estrogens—ESR1—decidua—ovarian cancer	0.000378	0.00555	CbGeAlD
Conjugated Estrogens—COMT—female gonad—ovarian cancer	0.000377	0.00552	CbGeAlD
Conjugated Estrogens—ABCC4—uterus—ovarian cancer	0.000375	0.00551	CbGeAlD
Conjugated Estrogens—COMT—vagina—ovarian cancer	0.000374	0.00549	CbGeAlD
Conjugated Estrogens—ABCC3—female gonad—ovarian cancer	0.000372	0.00546	CbGeAlD
Conjugated Estrogens—ABCC1—decidua—ovarian cancer	0.000366	0.00537	CbGeAlD
Conjugated Estrogens—ESR1—endometrium—ovarian cancer	0.000359	0.00527	CbGeAlD
Conjugated Estrogens—SLCO1C1—lymph node—ovarian cancer	0.000357	0.00524	CbGeAlD
Conjugated Estrogens—ESR2—testis—ovarian cancer	0.00035	0.00514	CbGeAlD
Conjugated Estrogens—ABCC1—endometrium—ovarian cancer	0.000347	0.00509	CbGeAlD
Conjugated Estrogens—SLCO2B1—female gonad—ovarian cancer	0.000347	0.00509	CbGeAlD
Conjugated Estrogens—ABCC4—female reproductive system—ovarian cancer	0.000337	0.00495	CbGeAlD
Conjugated Estrogens—COMT—testis—ovarian cancer	0.000334	0.0049	CbGeAlD
Conjugated Estrogens—ESR1—gonad—ovarian cancer	0.000333	0.00488	CbGeAlD
Conjugated Estrogens—ESR1—uterus—ovarian cancer	0.000331	0.00485	CbGeAlD
Conjugated Estrogens—ABCC3—testis—ovarian cancer	0.00033	0.00484	CbGeAlD
Conjugated Estrogens—ABCC2—female reproductive system—ovarian cancer	0.000327	0.00479	CbGeAlD
Conjugated Estrogens—Estropipate—ESR1—ovarian cancer	0.000321	0.0815	CrCbGaD
Conjugated Estrogens—ABCC1—uterus—ovarian cancer	0.00032	0.00469	CbGeAlD
Conjugated Estrogens—ABCC4—bone marrow—ovarian cancer	0.000319	0.00467	CbGeAlD
Conjugated Estrogens—ABCG2—uterine cervix—ovarian cancer	0.000318	0.00466	CbGeAlD
Conjugated Estrogens—SLCO3A1—lymph node—ovarian cancer	0.000314	0.00461	CbGeAlD
Conjugated Estrogens—SLCO2B1—testis—ovarian cancer	0.000308	0.00451	CbGeAlD
Conjugated Estrogens—ABCC4—female gonad—ovarian cancer	0.000307	0.0045	CbGeAlD
Conjugated Estrogens—ABCG2—decidua—ovarian cancer	0.000303	0.00444	CbGeAlD
Conjugated Estrogens—ESR1—female reproductive system—ovarian cancer	0.000297	0.00436	CbGeAlD
Conjugated Estrogens—Estrone—CYP1B1—ovarian cancer	0.000296	0.0751	CrCbGaD
Conjugated Estrogens—ABCG2—endometrium—ovarian cancer	0.000288	0.00422	CbGeAlD
Conjugated Estrogens—SLCO4A1—lymph node—ovarian cancer	0.000286	0.0042	CbGeAlD
Conjugated Estrogens—SLCO1A2—testis—ovarian cancer	0.000283	0.00415	CbGeAlD
Conjugated Estrogens—ABCC4—testis—ovarian cancer	0.000272	0.00399	CbGeAlD
Conjugated Estrogens—ESR1—female gonad—ovarian cancer	0.000271	0.00397	CbGeAlD
Conjugated Estrogens—ESR1—vagina—ovarian cancer	0.000269	0.00394	CbGeAlD
Conjugated Estrogens—ABCG2—uterus—ovarian cancer	0.000265	0.00389	CbGeAlD
Conjugated Estrogens—ABCC2—testis—ovarian cancer	0.000264	0.00387	CbGeAlD
Conjugated Estrogens—ABCC1—female gonad—ovarian cancer	0.000262	0.00384	CbGeAlD
Conjugated Estrogens—ABCC1—vagina—ovarian cancer	0.00026	0.00382	CbGeAlD
Conjugated Estrogens—ESR2—lymph node—ovarian cancer	0.000254	0.00373	CbGeAlD
Conjugated Estrogens—COMT—lymph node—ovarian cancer	0.000242	0.00355	CbGeAlD
Conjugated Estrogens—ESR1—testis—ovarian cancer	0.00024	0.00352	CbGeAlD
Conjugated Estrogens—ABCC3—lymph node—ovarian cancer	0.000239	0.00351	CbGeAlD
Conjugated Estrogens—ABCC1—testis—ovarian cancer	0.000232	0.00341	CbGeAlD
Conjugated Estrogens—Ethinyl Estradiol—ESR1—ovarian cancer	0.000229	0.0582	CrCbGaD
Conjugated Estrogens—ABCG2—bone marrow—ovarian cancer	0.000225	0.0033	CbGeAlD
Conjugated Estrogens—Estradiol—CYP1B1—ovarian cancer	0.000224	0.0569	CrCbGaD
Conjugated Estrogens—SLCO2B1—lymph node—ovarian cancer	0.000223	0.00327	CbGeAlD
Conjugated Estrogens—ABCG2—female gonad—ovarian cancer	0.000217	0.00318	CbGeAlD
Conjugated Estrogens—ABCG2—vagina—ovarian cancer	0.000215	0.00316	CbGeAlD
Conjugated Estrogens—ABCB1—myometrium—ovarian cancer	0.000201	0.00295	CbGeAlD
Conjugated Estrogens—Estrone—ESR1—ovarian cancer	0.0002	0.0507	CrCbGaD
Conjugated Estrogens—ABCC4—lymph node—ovarian cancer	0.000197	0.0029	CbGeAlD
Conjugated Estrogens—ABCB1—embryo—ovarian cancer	0.000194	0.00284	CbGeAlD
Conjugated Estrogens—ABCG2—testis—ovarian cancer	0.000192	0.00282	CbGeAlD
Conjugated Estrogens—ABCC2—lymph node—ovarian cancer	0.000191	0.0028	CbGeAlD
Conjugated Estrogens—Estriol—ABCB1—ovarian cancer	0.000178	0.0453	CrCbGaD
Conjugated Estrogens—ESR1—lymph node—ovarian cancer	0.000174	0.00255	CbGeAlD
Conjugated Estrogens—ABCC1—lymph node—ovarian cancer	0.000168	0.00247	CbGeAlD
Conjugated Estrogens—CYP3A4—female reproductive system—ovarian cancer	0.000166	0.00243	CbGeAlD
Conjugated Estrogens—Estramustine—ABCB1—ovarian cancer	0.000166	0.0421	CrCbGaD
Conjugated Estrogens—ABCB1—epithelium—ovarian cancer	0.000158	0.00232	CbGeAlD
Conjugated Estrogens—ABCB1—uterine cervix—ovarian cancer	0.000157	0.0023	CbGeAlD
Conjugated Estrogens—Estradiol—ESR1—ovarian cancer	0.000151	0.0384	CrCbGaD
Conjugated Estrogens—ABCB1—decidua—ovarian cancer	0.000149	0.00219	CbGeAlD
Conjugated Estrogens—ABCB1—endometrium—ovarian cancer	0.000142	0.00208	CbGeAlD
Conjugated Estrogens—ABCG2—lymph node—ovarian cancer	0.000139	0.00204	CbGeAlD
Conjugated Estrogens—ABCB1—gonad—ovarian cancer	0.000132	0.00193	CbGeAlD
Conjugated Estrogens—ABCB1—uterus—ovarian cancer	0.000131	0.00192	CbGeAlD
Conjugated Estrogens—ABCB1—female reproductive system—ovarian cancer	0.000117	0.00172	CbGeAlD
Conjugated Estrogens—ABCB1—bone marrow—ovarian cancer	0.000111	0.00163	CbGeAlD
Conjugated Estrogens—ABCB1—female gonad—ovarian cancer	0.000107	0.00157	CbGeAlD
Conjugated Estrogens—ABCB1—vagina—ovarian cancer	0.000106	0.00156	CbGeAlD
Conjugated Estrogens—Ethinyl Estradiol—ABCB1—ovarian cancer	9.75e-05	0.0247	CrCbGaD
Conjugated Estrogens—ABCB1—testis—ovarian cancer	9.48e-05	0.00139	CbGeAlD
Conjugated Estrogens—Estrone—ABCB1—ovarian cancer	8.49e-05	0.0216	CrCbGaD
Conjugated Estrogens—Muscle spasms—Docetaxel—ovarian cancer	8.27e-05	0.00063	CcSEcCtD
Conjugated Estrogens—Infection—Paclitaxel—ovarian cancer	8.23e-05	0.000627	CcSEcCtD
Conjugated Estrogens—Pancreatitis—Epirubicin—ovarian cancer	8.16e-05	0.000622	CcSEcCtD
Conjugated Estrogens—Shock—Paclitaxel—ovarian cancer	8.15e-05	0.000621	CcSEcCtD
Conjugated Estrogens—Dizziness—Vinorelbine—ovarian cancer	8.14e-05	0.00062	CcSEcCtD
Conjugated Estrogens—Nervous system disorder—Paclitaxel—ovarian cancer	8.12e-05	0.000619	CcSEcCtD
Conjugated Estrogens—Hypokalaemia—Doxorubicin—ovarian cancer	8.11e-05	0.000618	CcSEcCtD
Conjugated Estrogens—Tachycardia—Paclitaxel—ovarian cancer	8.08e-05	0.000616	CcSEcCtD
Conjugated Estrogens—Breast disorder—Doxorubicin—ovarian cancer	8.05e-05	0.000614	CcSEcCtD
Conjugated Estrogens—Skin disorder—Paclitaxel—ovarian cancer	8.04e-05	0.000613	CcSEcCtD
Conjugated Estrogens—Bronchitis—Epirubicin—ovarian cancer	8.01e-05	0.00061	CcSEcCtD
Conjugated Estrogens—Hyperhidrosis—Paclitaxel—ovarian cancer	8.01e-05	0.00061	CcSEcCtD
Conjugated Estrogens—Anorexia—Paclitaxel—ovarian cancer	7.89e-05	0.000602	CcSEcCtD
Conjugated Estrogens—Vomiting—Vinorelbine—ovarian cancer	7.83e-05	0.000597	CcSEcCtD
Conjugated Estrogens—Dysuria—Epirubicin—ovarian cancer	7.78e-05	0.000593	CcSEcCtD
Conjugated Estrogens—Rash—Vinorelbine—ovarian cancer	7.76e-05	0.000592	CcSEcCtD
Conjugated Estrogens—Dermatitis—Vinorelbine—ovarian cancer	7.76e-05	0.000591	CcSEcCtD
Conjugated Estrogens—Abdominal distension—Doxorubicin—ovarian cancer	7.75e-05	0.000591	CcSEcCtD
Conjugated Estrogens—Hypotension—Paclitaxel—ovarian cancer	7.74e-05	0.00059	CcSEcCtD
Conjugated Estrogens—Upper respiratory tract infection—Epirubicin—ovarian cancer	7.74e-05	0.00059	CcSEcCtD
Conjugated Estrogens—Headache—Vinorelbine—ovarian cancer	7.71e-05	0.000588	CcSEcCtD
Conjugated Estrogens—Syncope—Docetaxel—ovarian cancer	7.71e-05	0.000588	CcSEcCtD
Conjugated Estrogens—Asthma—Doxorubicin—ovarian cancer	7.7e-05	0.000587	CcSEcCtD
Conjugated Estrogens—Influenza—Doxorubicin—ovarian cancer	7.7e-05	0.000587	CcSEcCtD
Conjugated Estrogens—Dysphagia—Doxorubicin—ovarian cancer	7.7e-05	0.000587	CcSEcCtD
Conjugated Estrogens—Palpitations—Docetaxel—ovarian cancer	7.6e-05	0.000579	CcSEcCtD
Conjugated Estrogens—Weight increased—Epirubicin—ovarian cancer	7.58e-05	0.000577	CcSEcCtD
Conjugated Estrogens—Loss of consciousness—Docetaxel—ovarian cancer	7.56e-05	0.000576	CcSEcCtD
Conjugated Estrogens—Pancreatitis—Doxorubicin—ovarian cancer	7.55e-05	0.000576	CcSEcCtD
Conjugated Estrogens—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	7.54e-05	0.000575	CcSEcCtD
Conjugated Estrogens—Hyperglycaemia—Epirubicin—ovarian cancer	7.51e-05	0.000572	CcSEcCtD
Conjugated Estrogens—Cough—Docetaxel—ovarian cancer	7.5e-05	0.000572	CcSEcCtD
Conjugated Estrogens—Insomnia—Paclitaxel—ovarian cancer	7.49e-05	0.000571	CcSEcCtD
Conjugated Estrogens—Convulsion—Docetaxel—ovarian cancer	7.45e-05	0.000568	CcSEcCtD
Conjugated Estrogens—Paraesthesia—Paclitaxel—ovarian cancer	7.44e-05	0.000567	CcSEcCtD
Conjugated Estrogens—Infestation NOS—Epirubicin—ovarian cancer	7.42e-05	0.000566	CcSEcCtD
Conjugated Estrogens—Infestation—Epirubicin—ovarian cancer	7.42e-05	0.000566	CcSEcCtD
Conjugated Estrogens—Bronchitis—Doxorubicin—ovarian cancer	7.41e-05	0.000565	CcSEcCtD
Conjugated Estrogens—Dyspnoea—Paclitaxel—ovarian cancer	7.38e-05	0.000563	CcSEcCtD
Conjugated Estrogens—Somnolence—Paclitaxel—ovarian cancer	7.36e-05	0.000561	CcSEcCtD
Conjugated Estrogens—Arthralgia—Docetaxel—ovarian cancer	7.32e-05	0.000558	CcSEcCtD
Conjugated Estrogens—Chest pain—Docetaxel—ovarian cancer	7.32e-05	0.000558	CcSEcCtD
Conjugated Estrogens—Myalgia—Docetaxel—ovarian cancer	7.32e-05	0.000558	CcSEcCtD
Conjugated Estrogens—Nausea—Vinorelbine—ovarian cancer	7.31e-05	0.000557	CcSEcCtD
Conjugated Estrogens—Renal failure—Epirubicin—ovarian cancer	7.3e-05	0.000556	CcSEcCtD
Conjugated Estrogens—Dyspepsia—Paclitaxel—ovarian cancer	7.29e-05	0.000556	CcSEcCtD
Conjugated Estrogens—Neuropathy peripheral—Epirubicin—ovarian cancer	7.28e-05	0.000555	CcSEcCtD
Conjugated Estrogens—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	7.27e-05	0.000554	CcSEcCtD
Conjugated Estrogens—Dysuria—Doxorubicin—ovarian cancer	7.2e-05	0.000549	CcSEcCtD
Conjugated Estrogens—Decreased appetite—Paclitaxel—ovarian cancer	7.2e-05	0.000549	CcSEcCtD
Conjugated Estrogens—Upper respiratory tract infection—Doxorubicin—ovarian cancer	7.16e-05	0.000546	CcSEcCtD
Conjugated Estrogens—Gastrointestinal disorder—Paclitaxel—ovarian cancer	7.15e-05	0.000545	CcSEcCtD
Conjugated Estrogens—Fatigue—Paclitaxel—ovarian cancer	7.14e-05	0.000544	CcSEcCtD
Conjugated Estrogens—Pain—Paclitaxel—ovarian cancer	7.08e-05	0.00054	CcSEcCtD
Conjugated Estrogens—Constipation—Paclitaxel—ovarian cancer	7.08e-05	0.00054	CcSEcCtD
Conjugated Estrogens—Hepatobiliary disease—Epirubicin—ovarian cancer	7.02e-05	0.000535	CcSEcCtD
Conjugated Estrogens—Anaphylactic shock—Docetaxel—ovarian cancer	7.02e-05	0.000535	CcSEcCtD
Conjugated Estrogens—Oedema—Docetaxel—ovarian cancer	7.02e-05	0.000535	CcSEcCtD
Conjugated Estrogens—Weight increased—Doxorubicin—ovarian cancer	7.01e-05	0.000534	CcSEcCtD
Conjugated Estrogens—Infection—Docetaxel—ovarian cancer	6.97e-05	0.000531	CcSEcCtD
Conjugated Estrogens—Sinusitis—Epirubicin—ovarian cancer	6.96e-05	0.000531	CcSEcCtD
Conjugated Estrogens—Hyperglycaemia—Doxorubicin—ovarian cancer	6.95e-05	0.00053	CcSEcCtD
Conjugated Estrogens—Shock—Docetaxel—ovarian cancer	6.91e-05	0.000526	CcSEcCtD
Conjugated Estrogens—Nervous system disorder—Docetaxel—ovarian cancer	6.88e-05	0.000525	CcSEcCtD
Conjugated Estrogens—ABCB1—lymph node—ovarian cancer	6.87e-05	0.00101	CbGeAlD
Conjugated Estrogens—Infestation NOS—Doxorubicin—ovarian cancer	6.87e-05	0.000523	CcSEcCtD
Conjugated Estrogens—Infestation—Doxorubicin—ovarian cancer	6.87e-05	0.000523	CcSEcCtD
Conjugated Estrogens—Tachycardia—Docetaxel—ovarian cancer	6.85e-05	0.000522	CcSEcCtD
Conjugated Estrogens—Skin disorder—Docetaxel—ovarian cancer	6.82e-05	0.00052	CcSEcCtD
Conjugated Estrogens—Gastrointestinal pain—Paclitaxel—ovarian cancer	6.77e-05	0.000516	CcSEcCtD
Conjugated Estrogens—Renal failure—Doxorubicin—ovarian cancer	6.75e-05	0.000515	CcSEcCtD
Conjugated Estrogens—Neuropathy peripheral—Doxorubicin—ovarian cancer	6.73e-05	0.000513	CcSEcCtD
Conjugated Estrogens—Anorexia—Docetaxel—ovarian cancer	6.69e-05	0.00051	CcSEcCtD
Conjugated Estrogens—Rhinitis—Epirubicin—ovarian cancer	6.68e-05	0.000509	CcSEcCtD
Conjugated Estrogens—Hypoaesthesia—Epirubicin—ovarian cancer	6.63e-05	0.000505	CcSEcCtD
Conjugated Estrogens—Pharyngitis—Epirubicin—ovarian cancer	6.61e-05	0.000504	CcSEcCtD
Conjugated Estrogens—Urticaria—Paclitaxel—ovarian cancer	6.58e-05	0.000501	CcSEcCtD
Conjugated Estrogens—Oedema peripheral—Epirubicin—ovarian cancer	6.56e-05	0.0005	CcSEcCtD
Conjugated Estrogens—Hypotension—Docetaxel—ovarian cancer	6.56e-05	0.0005	CcSEcCtD
Conjugated Estrogens—Abdominal pain—Paclitaxel—ovarian cancer	6.55e-05	0.000499	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Paclitaxel—ovarian cancer	6.55e-05	0.000499	CcSEcCtD
Conjugated Estrogens—Hepatobiliary disease—Doxorubicin—ovarian cancer	6.5e-05	0.000495	CcSEcCtD
Conjugated Estrogens—Sinusitis—Doxorubicin—ovarian cancer	6.44e-05	0.000491	CcSEcCtD
Conjugated Estrogens—Estradiol—ABCB1—ovarian cancer	6.44e-05	0.0163	CrCbGaD
Conjugated Estrogens—Visual impairment—Epirubicin—ovarian cancer	6.42e-05	0.000489	CcSEcCtD
Conjugated Estrogens—Musculoskeletal discomfort—Docetaxel—ovarian cancer	6.39e-05	0.000487	CcSEcCtD
Conjugated Estrogens—Insomnia—Docetaxel—ovarian cancer	6.35e-05	0.000484	CcSEcCtD
Conjugated Estrogens—Paraesthesia—Docetaxel—ovarian cancer	6.3e-05	0.00048	CcSEcCtD
Conjugated Estrogens—Erythema multiforme—Epirubicin—ovarian cancer	6.3e-05	0.00048	CcSEcCtD
Conjugated Estrogens—Dyspnoea—Docetaxel—ovarian cancer	6.26e-05	0.000477	CcSEcCtD
Conjugated Estrogens—Somnolence—Docetaxel—ovarian cancer	6.24e-05	0.000476	CcSEcCtD
Conjugated Estrogens—Eye disorder—Epirubicin—ovarian cancer	6.23e-05	0.000475	CcSEcCtD
Conjugated Estrogens—Cardiac disorder—Epirubicin—ovarian cancer	6.18e-05	0.000471	CcSEcCtD
Conjugated Estrogens—Rhinitis—Doxorubicin—ovarian cancer	6.18e-05	0.000471	CcSEcCtD
Conjugated Estrogens—Dyspepsia—Docetaxel—ovarian cancer	6.18e-05	0.000471	CcSEcCtD
Conjugated Estrogens—Hypoaesthesia—Doxorubicin—ovarian cancer	6.13e-05	0.000468	CcSEcCtD
Conjugated Estrogens—Pharyngitis—Doxorubicin—ovarian cancer	6.12e-05	0.000466	CcSEcCtD
Conjugated Estrogens—Decreased appetite—Docetaxel—ovarian cancer	6.1e-05	0.000465	CcSEcCtD
Conjugated Estrogens—Hypersensitivity—Paclitaxel—ovarian cancer	6.1e-05	0.000465	CcSEcCtD
Conjugated Estrogens—Oedema peripheral—Doxorubicin—ovarian cancer	6.07e-05	0.000463	CcSEcCtD
Conjugated Estrogens—Gastrointestinal disorder—Docetaxel—ovarian cancer	6.06e-05	0.000462	CcSEcCtD
Conjugated Estrogens—Fatigue—Docetaxel—ovarian cancer	6.05e-05	0.000461	CcSEcCtD
Conjugated Estrogens—Angiopathy—Epirubicin—ovarian cancer	6.05e-05	0.000461	CcSEcCtD
Conjugated Estrogens—Immune system disorder—Epirubicin—ovarian cancer	6.02e-05	0.000459	CcSEcCtD
Conjugated Estrogens—Mediastinal disorder—Epirubicin—ovarian cancer	6.01e-05	0.000458	CcSEcCtD
Conjugated Estrogens—Constipation—Docetaxel—ovarian cancer	6e-05	0.000457	CcSEcCtD
Conjugated Estrogens—Pain—Docetaxel—ovarian cancer	6e-05	0.000457	CcSEcCtD
Conjugated Estrogens—Arrhythmia—Epirubicin—ovarian cancer	5.95e-05	0.000454	CcSEcCtD
Conjugated Estrogens—Visual impairment—Doxorubicin—ovarian cancer	5.94e-05	0.000453	CcSEcCtD
Conjugated Estrogens—Asthenia—Paclitaxel—ovarian cancer	5.94e-05	0.000453	CcSEcCtD
Conjugated Estrogens—Alopecia—Epirubicin—ovarian cancer	5.89e-05	0.000449	CcSEcCtD
Conjugated Estrogens—Pruritus—Paclitaxel—ovarian cancer	5.86e-05	0.000446	CcSEcCtD
Conjugated Estrogens—Mental disorder—Epirubicin—ovarian cancer	5.84e-05	0.000445	CcSEcCtD
Conjugated Estrogens—Erythema multiforme—Doxorubicin—ovarian cancer	5.83e-05	0.000444	CcSEcCtD
Conjugated Estrogens—Malnutrition—Epirubicin—ovarian cancer	5.8e-05	0.000442	CcSEcCtD
Conjugated Estrogens—Erythema—Epirubicin—ovarian cancer	5.8e-05	0.000442	CcSEcCtD
Conjugated Estrogens—Eye disorder—Doxorubicin—ovarian cancer	5.76e-05	0.000439	CcSEcCtD
Conjugated Estrogens—Gastrointestinal pain—Docetaxel—ovarian cancer	5.74e-05	0.000437	CcSEcCtD
Conjugated Estrogens—Cardiac disorder—Doxorubicin—ovarian cancer	5.72e-05	0.000436	CcSEcCtD
Conjugated Estrogens—Flatulence—Epirubicin—ovarian cancer	5.72e-05	0.000436	CcSEcCtD
Conjugated Estrogens—Tension—Epirubicin—ovarian cancer	5.69e-05	0.000434	CcSEcCtD
Conjugated Estrogens—Dysgeusia—Epirubicin—ovarian cancer	5.68e-05	0.000433	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Paclitaxel—ovarian cancer	5.67e-05	0.000432	CcSEcCtD
Conjugated Estrogens—Nervousness—Epirubicin—ovarian cancer	5.63e-05	0.000429	CcSEcCtD
Conjugated Estrogens—Back pain—Epirubicin—ovarian cancer	5.61e-05	0.000428	CcSEcCtD
Conjugated Estrogens—Angiopathy—Doxorubicin—ovarian cancer	5.59e-05	0.000426	CcSEcCtD
Conjugated Estrogens—Muscle spasms—Epirubicin—ovarian cancer	5.58e-05	0.000425	CcSEcCtD
Conjugated Estrogens—Immune system disorder—Doxorubicin—ovarian cancer	5.57e-05	0.000424	CcSEcCtD
Conjugated Estrogens—Mediastinal disorder—Doxorubicin—ovarian cancer	5.56e-05	0.000423	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Docetaxel—ovarian cancer	5.55e-05	0.000423	CcSEcCtD
Conjugated Estrogens—Abdominal pain—Docetaxel—ovarian cancer	5.55e-05	0.000423	CcSEcCtD
Conjugated Estrogens—Arrhythmia—Doxorubicin—ovarian cancer	5.51e-05	0.00042	CcSEcCtD
Conjugated Estrogens—Dizziness—Paclitaxel—ovarian cancer	5.48e-05	0.000417	CcSEcCtD
Conjugated Estrogens—Vision blurred—Epirubicin—ovarian cancer	5.47e-05	0.000417	CcSEcCtD
Conjugated Estrogens—Alopecia—Doxorubicin—ovarian cancer	5.45e-05	0.000415	CcSEcCtD
Conjugated Estrogens—Mental disorder—Doxorubicin—ovarian cancer	5.4e-05	0.000412	CcSEcCtD
Conjugated Estrogens—Malnutrition—Doxorubicin—ovarian cancer	5.37e-05	0.000409	CcSEcCtD
Conjugated Estrogens—Erythema—Doxorubicin—ovarian cancer	5.37e-05	0.000409	CcSEcCtD
Conjugated Estrogens—Flatulence—Doxorubicin—ovarian cancer	5.29e-05	0.000403	CcSEcCtD
Conjugated Estrogens—Tension—Doxorubicin—ovarian cancer	5.27e-05	0.000401	CcSEcCtD
Conjugated Estrogens—Vomiting—Paclitaxel—ovarian cancer	5.27e-05	0.000401	CcSEcCtD
Conjugated Estrogens—Dysgeusia—Doxorubicin—ovarian cancer	5.26e-05	0.000401	CcSEcCtD
Conjugated Estrogens—Rash—Paclitaxel—ovarian cancer	5.22e-05	0.000398	CcSEcCtD
Conjugated Estrogens—Dermatitis—Paclitaxel—ovarian cancer	5.22e-05	0.000398	CcSEcCtD
Conjugated Estrogens—Nervousness—Doxorubicin—ovarian cancer	5.21e-05	0.000397	CcSEcCtD
Conjugated Estrogens—Vertigo—Epirubicin—ovarian cancer	5.21e-05	0.000397	CcSEcCtD
Conjugated Estrogens—Syncope—Epirubicin—ovarian cancer	5.2e-05	0.000396	CcSEcCtD
Conjugated Estrogens—Back pain—Doxorubicin—ovarian cancer	5.19e-05	0.000396	CcSEcCtD
Conjugated Estrogens—Headache—Paclitaxel—ovarian cancer	5.19e-05	0.000395	CcSEcCtD
Conjugated Estrogens—Hypersensitivity—Docetaxel—ovarian cancer	5.17e-05	0.000394	CcSEcCtD
Conjugated Estrogens—Muscle spasms—Doxorubicin—ovarian cancer	5.16e-05	0.000393	CcSEcCtD
Conjugated Estrogens—Palpitations—Epirubicin—ovarian cancer	5.13e-05	0.000391	CcSEcCtD
Conjugated Estrogens—Loss of consciousness—Epirubicin—ovarian cancer	5.1e-05	0.000389	CcSEcCtD
Conjugated Estrogens—Cough—Epirubicin—ovarian cancer	5.06e-05	0.000386	CcSEcCtD
Conjugated Estrogens—Vision blurred—Doxorubicin—ovarian cancer	5.06e-05	0.000386	CcSEcCtD
Conjugated Estrogens—Asthenia—Docetaxel—ovarian cancer	5.04e-05	0.000384	CcSEcCtD
Conjugated Estrogens—Convulsion—Epirubicin—ovarian cancer	5.03e-05	0.000383	CcSEcCtD
Conjugated Estrogens—Pruritus—Docetaxel—ovarian cancer	4.97e-05	0.000378	CcSEcCtD
Conjugated Estrogens—Arthralgia—Epirubicin—ovarian cancer	4.94e-05	0.000376	CcSEcCtD
Conjugated Estrogens—Chest pain—Epirubicin—ovarian cancer	4.94e-05	0.000376	CcSEcCtD
Conjugated Estrogens—Myalgia—Epirubicin—ovarian cancer	4.94e-05	0.000376	CcSEcCtD
Conjugated Estrogens—Anxiety—Epirubicin—ovarian cancer	4.92e-05	0.000375	CcSEcCtD
Conjugated Estrogens—Nausea—Paclitaxel—ovarian cancer	4.92e-05	0.000375	CcSEcCtD
Conjugated Estrogens—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	4.9e-05	0.000374	CcSEcCtD
Conjugated Estrogens—Vertigo—Doxorubicin—ovarian cancer	4.82e-05	0.000368	CcSEcCtD
Conjugated Estrogens—Syncope—Doxorubicin—ovarian cancer	4.81e-05	0.000367	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Docetaxel—ovarian cancer	4.8e-05	0.000366	CcSEcCtD
Conjugated Estrogens—Palpitations—Doxorubicin—ovarian cancer	4.74e-05	0.000361	CcSEcCtD
Conjugated Estrogens—Anaphylactic shock—Epirubicin—ovarian cancer	4.73e-05	0.000361	CcSEcCtD
Conjugated Estrogens—Oedema—Epirubicin—ovarian cancer	4.73e-05	0.000361	CcSEcCtD
Conjugated Estrogens—Loss of consciousness—Doxorubicin—ovarian cancer	4.72e-05	0.00036	CcSEcCtD
Conjugated Estrogens—Infection—Epirubicin—ovarian cancer	4.7e-05	0.000358	CcSEcCtD
Conjugated Estrogens—Cough—Doxorubicin—ovarian cancer	4.68e-05	0.000357	CcSEcCtD
Conjugated Estrogens—Shock—Epirubicin—ovarian cancer	4.66e-05	0.000355	CcSEcCtD
Conjugated Estrogens—Convulsion—Doxorubicin—ovarian cancer	4.65e-05	0.000354	CcSEcCtD
Conjugated Estrogens—Nervous system disorder—Epirubicin—ovarian cancer	4.64e-05	0.000354	CcSEcCtD
Conjugated Estrogens—Dizziness—Docetaxel—ovarian cancer	4.64e-05	0.000354	CcSEcCtD
Conjugated Estrogens—Tachycardia—Epirubicin—ovarian cancer	4.62e-05	0.000352	CcSEcCtD
Conjugated Estrogens—Skin disorder—Epirubicin—ovarian cancer	4.6e-05	0.00035	CcSEcCtD
Conjugated Estrogens—Hyperhidrosis—Epirubicin—ovarian cancer	4.58e-05	0.000349	CcSEcCtD
Conjugated Estrogens—Arthralgia—Doxorubicin—ovarian cancer	4.57e-05	0.000348	CcSEcCtD
Conjugated Estrogens—Myalgia—Doxorubicin—ovarian cancer	4.57e-05	0.000348	CcSEcCtD
Conjugated Estrogens—Chest pain—Doxorubicin—ovarian cancer	4.57e-05	0.000348	CcSEcCtD
Conjugated Estrogens—Anxiety—Doxorubicin—ovarian cancer	4.55e-05	0.000347	CcSEcCtD
Conjugated Estrogens—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	4.54e-05	0.000346	CcSEcCtD
Conjugated Estrogens—Anorexia—Epirubicin—ovarian cancer	4.51e-05	0.000344	CcSEcCtD
Conjugated Estrogens—Vomiting—Docetaxel—ovarian cancer	4.46e-05	0.00034	CcSEcCtD
Conjugated Estrogens—Rash—Docetaxel—ovarian cancer	4.43e-05	0.000337	CcSEcCtD
Conjugated Estrogens—Hypotension—Epirubicin—ovarian cancer	4.42e-05	0.000337	CcSEcCtD
Conjugated Estrogens—Dermatitis—Docetaxel—ovarian cancer	4.42e-05	0.000337	CcSEcCtD
Conjugated Estrogens—Headache—Docetaxel—ovarian cancer	4.4e-05	0.000335	CcSEcCtD
Conjugated Estrogens—Anaphylactic shock—Doxorubicin—ovarian cancer	4.38e-05	0.000334	CcSEcCtD
Conjugated Estrogens—Oedema—Doxorubicin—ovarian cancer	4.38e-05	0.000334	CcSEcCtD
Conjugated Estrogens—Infection—Doxorubicin—ovarian cancer	4.35e-05	0.000332	CcSEcCtD
Conjugated Estrogens—Musculoskeletal discomfort—Epirubicin—ovarian cancer	4.31e-05	0.000329	CcSEcCtD
Conjugated Estrogens—Shock—Doxorubicin—ovarian cancer	4.31e-05	0.000328	CcSEcCtD
Conjugated Estrogens—Nervous system disorder—Doxorubicin—ovarian cancer	4.3e-05	0.000327	CcSEcCtD
Conjugated Estrogens—Insomnia—Epirubicin—ovarian cancer	4.28e-05	0.000326	CcSEcCtD
Conjugated Estrogens—Tachycardia—Doxorubicin—ovarian cancer	4.28e-05	0.000326	CcSEcCtD
Conjugated Estrogens—Skin disorder—Doxorubicin—ovarian cancer	4.25e-05	0.000324	CcSEcCtD
Conjugated Estrogens—Paraesthesia—Epirubicin—ovarian cancer	4.25e-05	0.000324	CcSEcCtD
Conjugated Estrogens—Hyperhidrosis—Doxorubicin—ovarian cancer	4.23e-05	0.000323	CcSEcCtD
Conjugated Estrogens—Dyspnoea—Epirubicin—ovarian cancer	4.22e-05	0.000322	CcSEcCtD
Conjugated Estrogens—Somnolence—Epirubicin—ovarian cancer	4.21e-05	0.000321	CcSEcCtD
Conjugated Estrogens—Anorexia—Doxorubicin—ovarian cancer	4.18e-05	0.000318	CcSEcCtD
Conjugated Estrogens—Nausea—Docetaxel—ovarian cancer	4.17e-05	0.000318	CcSEcCtD
Conjugated Estrogens—Dyspepsia—Epirubicin—ovarian cancer	4.17e-05	0.000318	CcSEcCtD
Conjugated Estrogens—Decreased appetite—Epirubicin—ovarian cancer	4.12e-05	0.000314	CcSEcCtD
Conjugated Estrogens—Hypotension—Doxorubicin—ovarian cancer	4.09e-05	0.000312	CcSEcCtD
Conjugated Estrogens—Gastrointestinal disorder—Epirubicin—ovarian cancer	4.09e-05	0.000311	CcSEcCtD
Conjugated Estrogens—Fatigue—Epirubicin—ovarian cancer	4.08e-05	0.000311	CcSEcCtD
Conjugated Estrogens—Pain—Epirubicin—ovarian cancer	4.05e-05	0.000309	CcSEcCtD
Conjugated Estrogens—Constipation—Epirubicin—ovarian cancer	4.05e-05	0.000309	CcSEcCtD
Conjugated Estrogens—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	3.99e-05	0.000304	CcSEcCtD
Conjugated Estrogens—Insomnia—Doxorubicin—ovarian cancer	3.96e-05	0.000302	CcSEcCtD
Conjugated Estrogens—Paraesthesia—Doxorubicin—ovarian cancer	3.93e-05	0.0003	CcSEcCtD
Conjugated Estrogens—Dyspnoea—Doxorubicin—ovarian cancer	3.91e-05	0.000298	CcSEcCtD
Conjugated Estrogens—Somnolence—Doxorubicin—ovarian cancer	3.89e-05	0.000297	CcSEcCtD
Conjugated Estrogens—Gastrointestinal pain—Epirubicin—ovarian cancer	3.87e-05	0.000295	CcSEcCtD
Conjugated Estrogens—Dyspepsia—Doxorubicin—ovarian cancer	3.86e-05	0.000294	CcSEcCtD
Conjugated Estrogens—Decreased appetite—Doxorubicin—ovarian cancer	3.81e-05	0.00029	CcSEcCtD
Conjugated Estrogens—Gastrointestinal disorder—Doxorubicin—ovarian cancer	3.78e-05	0.000288	CcSEcCtD
Conjugated Estrogens—Fatigue—Doxorubicin—ovarian cancer	3.78e-05	0.000288	CcSEcCtD
Conjugated Estrogens—Urticaria—Epirubicin—ovarian cancer	3.76e-05	0.000287	CcSEcCtD
Conjugated Estrogens—Pain—Doxorubicin—ovarian cancer	3.75e-05	0.000285	CcSEcCtD
Conjugated Estrogens—Constipation—Doxorubicin—ovarian cancer	3.75e-05	0.000285	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Epirubicin—ovarian cancer	3.74e-05	0.000285	CcSEcCtD
Conjugated Estrogens—Abdominal pain—Epirubicin—ovarian cancer	3.74e-05	0.000285	CcSEcCtD
Conjugated Estrogens—Gastrointestinal pain—Doxorubicin—ovarian cancer	3.58e-05	0.000273	CcSEcCtD
Conjugated Estrogens—Hypersensitivity—Epirubicin—ovarian cancer	3.49e-05	0.000266	CcSEcCtD
Conjugated Estrogens—Urticaria—Doxorubicin—ovarian cancer	3.48e-05	0.000265	CcSEcCtD
Conjugated Estrogens—Abdominal pain—Doxorubicin—ovarian cancer	3.46e-05	0.000264	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Doxorubicin—ovarian cancer	3.46e-05	0.000264	CcSEcCtD
Conjugated Estrogens—Asthenia—Epirubicin—ovarian cancer	3.4e-05	0.000259	CcSEcCtD
Conjugated Estrogens—Pruritus—Epirubicin—ovarian cancer	3.35e-05	0.000255	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Epirubicin—ovarian cancer	3.24e-05	0.000247	CcSEcCtD
Conjugated Estrogens—Hypersensitivity—Doxorubicin—ovarian cancer	3.23e-05	0.000246	CcSEcCtD
Conjugated Estrogens—Asthenia—Doxorubicin—ovarian cancer	3.14e-05	0.00024	CcSEcCtD
Conjugated Estrogens—Dizziness—Epirubicin—ovarian cancer	3.13e-05	0.000239	CcSEcCtD
Conjugated Estrogens—Pruritus—Doxorubicin—ovarian cancer	3.1e-05	0.000236	CcSEcCtD
Conjugated Estrogens—Vomiting—Epirubicin—ovarian cancer	3.01e-05	0.000229	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Doxorubicin—ovarian cancer	3e-05	0.000228	CcSEcCtD
Conjugated Estrogens—Rash—Epirubicin—ovarian cancer	2.98e-05	0.000227	CcSEcCtD
Conjugated Estrogens—Dermatitis—Epirubicin—ovarian cancer	2.98e-05	0.000227	CcSEcCtD
Conjugated Estrogens—Headache—Epirubicin—ovarian cancer	2.97e-05	0.000226	CcSEcCtD
Conjugated Estrogens—Dizziness—Doxorubicin—ovarian cancer	2.9e-05	0.000221	CcSEcCtD
Conjugated Estrogens—Nausea—Epirubicin—ovarian cancer	2.81e-05	0.000214	CcSEcCtD
Conjugated Estrogens—Vomiting—Doxorubicin—ovarian cancer	2.79e-05	0.000212	CcSEcCtD
Conjugated Estrogens—Rash—Doxorubicin—ovarian cancer	2.76e-05	0.00021	CcSEcCtD
Conjugated Estrogens—Dermatitis—Doxorubicin—ovarian cancer	2.76e-05	0.00021	CcSEcCtD
Conjugated Estrogens—Headache—Doxorubicin—ovarian cancer	2.74e-05	0.000209	CcSEcCtD
Conjugated Estrogens—Nausea—Doxorubicin—ovarian cancer	2.6e-05	0.000198	CcSEcCtD
Conjugated Estrogens—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.05e-05	0.000191	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—PPP2R1A—ovarian cancer	1.05e-05	0.000191	CbGpPWpGaD
Conjugated Estrogens—COMT—Metabolism—CAV1—ovarian cancer	1.05e-05	0.00019	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.05e-05	0.00019	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.03e-05	0.000188	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—CYP1B1—ovarian cancer	1.03e-05	0.000187	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—FASN—ovarian cancer	1.02e-05	0.000185	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	1.02e-05	0.000185	CbGpPWpGaD
Conjugated Estrogens—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	1.02e-05	0.000185	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—CYTB—ovarian cancer	1.01e-05	0.000184	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	1.01e-05	0.000184	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—SLC5A5—ovarian cancer	1e-05	0.000182	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	9.94e-06	0.00018	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	9.84e-06	0.000179	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—PPP2R1A—ovarian cancer	9.83e-06	0.000179	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—ABCB1—ovarian cancer	9.76e-06	0.000177	CbGpPWpGaD
Conjugated Estrogens—ABCC4—Hemostasis—VEGFA—ovarian cancer	9.76e-06	0.000177	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—NME2—ovarian cancer	9.7e-06	0.000176	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—FASN—ovarian cancer	9.69e-06	0.000176	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—SLC2A1—ovarian cancer	9.69e-06	0.000176	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	9.67e-06	0.000176	CbGpPWpGaD
Conjugated Estrogens—ABCC4—Hemostasis—NRAS—ovarian cancer	9.64e-06	0.000175	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—TYMS—ovarian cancer	9.59e-06	0.000174	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	9.58e-06	0.000174	CbGpPWpGaD
Conjugated Estrogens—COMT—Metabolism—PIK3CG—ovarian cancer	9.54e-06	0.000173	CbGpPWpGaD
Conjugated Estrogens—SLC10A1—Metabolism—PIK3CB—ovarian cancer	9.54e-06	0.000173	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—SLC5A5—ovarian cancer	9.53e-06	0.000173	CbGpPWpGaD
Conjugated Estrogens—ESR1—Gene Expression—PPP2R1A—ovarian cancer	9.52e-06	0.000173	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	9.48e-06	0.000172	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—YAP1—ovarian cancer	9.4e-06	0.000171	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	9.34e-06	0.000169	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—CYP1B1—ovarian cancer	9.29e-06	0.000169	CbGpPWpGaD
Conjugated Estrogens—ABCC4—Hemostasis—MAPK3—ovarian cancer	9.23e-06	0.000168	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—XIAP—ovarian cancer	9.21e-06	0.000167	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—SLC2A1—ovarian cancer	9.21e-06	0.000167	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—PPP2R1A—ovarian cancer	9.15e-06	0.000166	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	9.11e-06	0.000165	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	9.01e-06	0.000164	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—SMARCA4—ovarian cancer	8.98e-06	0.000163	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—FASN—ovarian cancer	8.97e-06	0.000163	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—PPP1CC—ovarian cancer	8.87e-06	0.000161	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—BRIP1—ovarian cancer	8.87e-06	0.000161	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—SLC5A5—ovarian cancer	8.83e-06	0.00016	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—CYP1B1—ovarian cancer	8.83e-06	0.00016	CbGpPWpGaD
Conjugated Estrogens—ABCC4—Hemostasis—MAPK1—ovarian cancer	8.78e-06	0.000159	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—EREG—ovarian cancer	8.76e-06	0.000159	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	8.7e-06	0.000158	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—CAV1—ovarian cancer	8.56e-06	0.000155	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—SLC2A1—ovarian cancer	8.52e-06	0.000155	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—ABCB1—ovarian cancer	8.5e-06	0.000154	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	8.43e-06	0.000153	CbGpPWpGaD
Conjugated Estrogens—COMT—Metabolism—PIK3CD—ovarian cancer	8.39e-06	0.000152	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—TYMS—ovarian cancer	8.35e-06	0.000152	CbGpPWpGaD
Conjugated Estrogens—ABCC4—Hemostasis—KRAS—ovarian cancer	8.29e-06	0.000151	CbGpPWpGaD
Conjugated Estrogens—SLC10A1—Metabolism—PTEN—ovarian cancer	8.24e-06	0.00015	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—PPP2R1A—ovarian cancer	8.24e-06	0.00015	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—PGR—ovarian cancer	8.21e-06	0.000149	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	8.2e-06	0.000149	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	8.18e-06	0.000148	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—CYP1B1—ovarian cancer	8.17e-06	0.000148	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—CYTB—ovarian cancer	8.1e-06	0.000147	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	7.98e-06	0.000145	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	7.92e-06	0.000144	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—PPP2R1A—ovarian cancer	7.83e-06	0.000142	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—TERT—ovarian cancer	7.81e-06	0.000142	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—PIK3CG—ovarian cancer	7.8e-06	0.000142	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	7.79e-06	0.000141	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	7.76e-06	0.000141	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—CAV1—ovarian cancer	7.72e-06	0.00014	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—ABCB1—ovarian cancer	7.65e-06	0.000139	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—PARP1—ovarian cancer	7.63e-06	0.000139	CbGpPWpGaD
Conjugated Estrogens—ABCC4—Hemostasis—PIK3CA—ovarian cancer	7.62e-06	0.000138	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	7.59e-06	0.000138	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	7.59e-06	0.000138	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—TYMS—ovarian cancer	7.51e-06	0.000136	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	7.38e-06	0.000134	CbGpPWpGaD
Conjugated Estrogens—ABCC4—Hemostasis—TP53—ovarian cancer	7.37e-06	0.000134	CbGpPWpGaD
Conjugated Estrogens—COMT—Metabolism—PIK3CB—ovarian cancer	7.31e-06	0.000133	CbGpPWpGaD
Conjugated Estrogens—ESR1—Generic Transcription Pathway—MYC—ovarian cancer	7.29e-06	0.000132	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—ABCB1—ovarian cancer	7.27e-06	0.000132	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—PPP2R1A—ovarian cancer	7.25e-06	0.000132	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—CAV1—ovarian cancer	7.23e-06	0.000131	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	7.17e-06	0.00013	CbGpPWpGaD
Conjugated Estrogens—ESR2—Gene Expression—MAPK3—ovarian cancer	7.15e-06	0.00013	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—TYMS—ovarian cancer	7.14e-06	0.00013	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—PPP1CC—ovarian cancer	7.08e-06	0.000129	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—BRIP1—ovarian cancer	7.08e-06	0.000129	CbGpPWpGaD
Conjugated Estrogens—ABCC4—Hemostasis—HRAS—ovarian cancer	7.05e-06	0.000128	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—PIK3CG—ovarian cancer	7.04e-06	0.000128	CbGpPWpGaD
Conjugated Estrogens—ESR2—Gene Expression—MYC—ovarian cancer	6.96e-06	0.000126	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—PIK3CD—ovarian cancer	6.85e-06	0.000124	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—IL6ST—ovarian cancer	6.85e-06	0.000124	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—ABCB1—ovarian cancer	6.73e-06	0.000122	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—CAV1—ovarian cancer	6.73e-06	0.000122	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—TYMS—ovarian cancer	6.61e-06	0.00012	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	6.59e-06	0.00012	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—APC—ovarian cancer	6.58e-06	0.000119	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	6.43e-06	0.000117	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	6.37e-06	0.000116	CbGpPWpGaD
Conjugated Estrogens—COMT—Metabolism—PTEN—ovarian cancer	6.32e-06	0.000115	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—CYTB—ovarian cancer	6.25e-06	0.000114	CbGpPWpGaD
Conjugated Estrogens—ABCC4—Hemostasis—AKT1—ovarian cancer	6.23e-06	0.000113	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—PPP2R1A—ovarian cancer	6.19e-06	0.000112	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—PIK3CD—ovarian cancer	6.18e-06	0.000112	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—PIK3CG—ovarian cancer	6.13e-06	0.000111	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—CAV1—ovarian cancer	6.05e-06	0.00011	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—PIK3CB—ovarian cancer	5.97e-06	0.000108	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—YAP1—ovarian cancer	5.95e-06	0.000108	CbGpPWpGaD
Conjugated Estrogens—SLC10A1—Metabolism—PIK3CA—ovarian cancer	5.82e-06	0.000106	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—PIK3CD—ovarian cancer	5.79e-06	0.000105	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	5.78e-06	0.000105	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—CAV1—ovarian cancer	5.75e-06	0.000104	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—PIK3CG—ovarian cancer	5.51e-06	0.0001	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	5.49e-06	9.97e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—PPP1CC—ovarian cancer	5.47e-06	9.92e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—BRIP1—ovarian cancer	5.47e-06	9.92e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—PIK3CB—ovarian cancer	5.39e-06	9.79e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—PIK3CD—ovarian cancer	5.39e-06	9.78e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	5.38e-06	9.77e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—CAV1—ovarian cancer	5.33e-06	9.67e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—PIK3CG—ovarian cancer	5.24e-06	9.51e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—PTEN—ovarian cancer	5.16e-06	9.37e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	5.16e-06	9.37e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—ERBB2—ovarian cancer	5.11e-06	9.28e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—MTOR—ovarian cancer	5.04e-06	9.16e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—PIK3CB—ovarian cancer	5.04e-06	9.16e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—TERT—ovarian cancer	4.92e-06	8.93e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—FASN—ovarian cancer	4.85e-06	8.8e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—PIK3CG—ovarian cancer	4.85e-06	8.8e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—PIK3CD—ovarian cancer	4.85e-06	8.8e-05	CbGpPWpGaD
Conjugated Estrogens—ESR2—Gene Expression—AKT1—ovarian cancer	4.82e-06	8.76e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—SLC5A5—ovarian cancer	4.77e-06	8.66e-05	CbGpPWpGaD
Conjugated Estrogens—SLC10A1—Metabolism—AKT1—ovarian cancer	4.75e-06	8.62e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—YAP1—ovarian cancer	4.75e-06	8.62e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—CDKN1B—ovarian cancer	4.73e-06	8.59e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	4.7e-06	8.53e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—PIK3CB—ovarian cancer	4.69e-06	8.52e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—PTEN—ovarian cancer	4.66e-06	8.46e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—SLC2A1—ovarian cancer	4.61e-06	8.36e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—PIK3CD—ovarian cancer	4.61e-06	8.36e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—CAV1—ovarian cancer	4.55e-06	8.26e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—CTNNB1—ovarian cancer	4.47e-06	8.12e-05	CbGpPWpGaD
Conjugated Estrogens—COMT—Metabolism—PIK3CA—ovarian cancer	4.46e-06	8.09e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—CYP1B1—ovarian cancer	4.42e-06	8.02e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—PTEN—ovarian cancer	4.36e-06	7.91e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—IL6ST—ovarian cancer	4.31e-06	7.83e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—PIK3CD—ovarian cancer	4.26e-06	7.74e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—PIK3CB—ovarian cancer	4.22e-06	7.67e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—APC—ovarian cancer	4.14e-06	7.52e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—PIK3CG—ovarian cancer	4.14e-06	7.52e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	4.13e-06	7.5e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—PTEN—ovarian cancer	4.06e-06	7.36e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—PIK3CB—ovarian cancer	4.01e-06	7.29e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—PPP2R1A—ovarian cancer	3.92e-06	7.11e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—STAT3—ovarian cancer	3.9e-06	7.08e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—NRAS—ovarian cancer	3.89e-06	7.06e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—FASN—ovarian cancer	3.87e-06	7.03e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—SLC5A5—ovarian cancer	3.81e-06	6.91e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—MAPK3—ovarian cancer	3.72e-06	6.76e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—PIK3CB—ovarian cancer	3.72e-06	6.75e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—SLC2A1—ovarian cancer	3.68e-06	6.68e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—YAP1—ovarian cancer	3.67e-06	6.65e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—PTEN—ovarian cancer	3.65e-06	6.63e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—PIK3CD—ovarian cancer	3.64e-06	6.61e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—PIK3CA—ovarian cancer	3.64e-06	6.61e-05	CbGpPWpGaD
Conjugated Estrogens—COMT—Metabolism—AKT1—ovarian cancer	3.64e-06	6.61e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—MYC—ovarian cancer	3.62e-06	6.57e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Gene Expression—MAPK3—ovarian cancer	3.61e-06	6.55e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	3.6e-06	6.54e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—TYMS—ovarian cancer	3.57e-06	6.49e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—MAPK1—ovarian cancer	3.54e-06	6.43e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—EGFR—ovarian cancer	3.54e-06	6.43e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—CYP1B1—ovarian cancer	3.53e-06	6.4e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Gene Expression—MYC—ovarian cancer	3.51e-06	6.37e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—PTEN—ovarian cancer	3.47e-06	6.3e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—KRAS—ovarian cancer	3.35e-06	6.07e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—PIK3CA—ovarian cancer	3.29e-06	5.97e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—ERBB2—ovarian cancer	3.22e-06	5.84e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—PTEN—ovarian cancer	3.21e-06	5.83e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—PIK3CB—ovarian cancer	3.18e-06	5.76e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—MTOR—ovarian cancer	3.18e-06	5.76e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—PPP2R1A—ovarian cancer	3.13e-06	5.68e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	3.11e-06	5.65e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—PIK3CA—ovarian cancer	3.07e-06	5.58e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—CXCL8—ovarian cancer	3.05e-06	5.54e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—FASN—ovarian cancer	2.99e-06	5.42e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—CDKN1B—ovarian cancer	2.98e-06	5.41e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—AKT1—ovarian cancer	2.98e-06	5.4e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—SLC5A5—ovarian cancer	2.94e-06	5.34e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—CASP3—ovarian cancer	2.92e-06	5.3e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—IL2—ovarian cancer	2.92e-06	5.29e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—ABCB1—ovarian cancer	2.9e-06	5.27e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—CAV1—ovarian cancer	2.88e-06	5.23e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—PIK3CA—ovarian cancer	2.86e-06	5.19e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—TYMS—ovarian cancer	2.85e-06	5.18e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—HRAS—ovarian cancer	2.84e-06	5.16e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—CCND1—ovarian cancer	2.84e-06	5.16e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—SLC2A1—ovarian cancer	2.84e-06	5.15e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—CTNNB1—ovarian cancer	2.82e-06	5.11e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—MMP9—ovarian cancer	2.76e-06	5.01e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—PTEN—ovarian cancer	2.74e-06	4.98e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—IL6—ovarian cancer	2.72e-06	4.94e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—CYP1B1—ovarian cancer	2.72e-06	4.94e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—AKT1—ovarian cancer	2.68e-06	4.87e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—PIK3CG—ovarian cancer	2.62e-06	4.76e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—PIK3CA—ovarian cancer	2.57e-06	4.67e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—AKT1—ovarian cancer	2.51e-06	4.56e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—VEGFA—ovarian cancer	2.48e-06	4.5e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—STAT3—ovarian cancer	2.45e-06	4.46e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—NRAS—ovarian cancer	2.45e-06	4.44e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—PIK3CA—ovarian cancer	2.45e-06	4.44e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Gene Expression—AKT1—ovarian cancer	2.43e-06	4.42e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	2.41e-06	4.38e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—MAPK3—ovarian cancer	2.34e-06	4.26e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—AKT1—ovarian cancer	2.34e-06	4.24e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—PIK3CD—ovarian cancer	2.31e-06	4.18e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—CAV1—ovarian cancer	2.3e-06	4.17e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—MYC—ovarian cancer	2.28e-06	4.14e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—PIK3CA—ovarian cancer	2.27e-06	4.11e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—ABCB1—ovarian cancer	2.24e-06	4.07e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—MAPK1—ovarian cancer	2.23e-06	4.05e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—EGFR—ovarian cancer	2.23e-06	4.05e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—TYMS—ovarian cancer	2.2e-06	4e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.2e-06	3.99e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—KRAS—ovarian cancer	2.11e-06	3.83e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—AKT1—ovarian cancer	2.1e-06	3.82e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—PIK3CG—ovarian cancer	2.09e-06	3.8e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—PIK3CB—ovarian cancer	2.01e-06	3.65e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—AKT1—ovarian cancer	2e-06	3.63e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—PIK3CA—ovarian cancer	1.94e-06	3.51e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—TP53—ovarian cancer	1.87e-06	3.4e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—AKT1—ovarian cancer	1.85e-06	3.36e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—PIK3CD—ovarian cancer	1.84e-06	3.34e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—HRAS—ovarian cancer	1.79e-06	3.25e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—CAV1—ovarian cancer	1.77e-06	3.22e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—PTEN—ovarian cancer	1.74e-06	3.15e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—IL6—ovarian cancer	1.71e-06	3.11e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—PIK3CG—ovarian cancer	1.62e-06	2.93e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—PIK3CB—ovarian cancer	1.6e-06	2.91e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—AKT1—ovarian cancer	1.58e-06	2.87e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—PIK3CD—ovarian cancer	1.42e-06	2.58e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—PTEN—ovarian cancer	1.39e-06	2.52e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—PIK3CB—ovarian cancer	1.24e-06	2.25e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—PIK3CA—ovarian cancer	1.23e-06	2.22e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—PTEN—ovarian cancer	1.07e-06	1.94e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—AKT1—ovarian cancer	1e-06	1.82e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—PIK3CA—ovarian cancer	9.78e-07	1.78e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—AKT1—ovarian cancer	7.99e-07	1.45e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—PIK3CA—ovarian cancer	7.55e-07	1.37e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—AKT1—ovarian cancer	6.17e-07	1.12e-05	CbGpPWpGaD
